SpineGuard S.A.
ALSGD.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.08 | -0.04 | -0.37 | 0.34 |
| FCF Yield | -25.75% | -49.30% | -12.41% | -6.14% |
| EV / EBITDA | -4.03 | -2.28 | -14.02 | -36.63 |
| Quality | ||||
| ROIC | -47.28% | -43.28% | -21.12% | -14.75% |
| Gross Margin | 78.06% | 78.35% | 80.64% | 77.80% |
| Cash Conversion Ratio | 0.76 | 0.87 | 0.74 | 0.87 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.02% | -0.70% | 4.89% | -13.59% |
| Free Cash Flow Growth | 28.83% | -70.44% | -19.50% | -63.48% |
| Safety | ||||
| Net Debt / EBITDA | -0.59 | -0.06 | 0.23 | 0.90 |
| Interest Coverage | -145.71 | -9.63 | -3.14 | -2.55 |
| Efficiency | ||||
| Inventory Turnover | 1.18 | 0.98 | 1.24 | 1.44 |
| Cash Conversion Cycle | -66.87 | -39.09 | -17.97 | -39.89 |